|
Lot Number N/A |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Death (1802); Hemorrhage/Bleeding (1888); Renal Failure (2041); Test Result (2695)
|
Event Type
Death
|
Manufacturer Narrative
|
Additional information has been requested from the customer, and will be reported if made available to us.
|
|
Event Description
|
The customer reported that the patient had a myocardial infarction (mi) and required intra-aortic balloon pump (iabp) therapy, which was inserted under fluoroscopy.This was reported to have been uneventful, and the patient was scheduled to be operated on when the patient's troponin levels dropped.As per hospital's ward protocol, the patient was put on a heparin infusion, and on the sixth (6th) postoperative day, it was reported that the patient had a retro-peritoneal bleed from the opposite groin to the iabp and was bleeding out.The heparin was stopped.The peritoneal bleed could have been evacuated, but was judged to be limited, and monitored instead.The patient subsequently went into renal failure, and died.The customer is questioning the use of heparin for the iabp patients and is specifically interested in the protocol for its use in iabp therapy, and is speculating if the use of heparin with the iabp may have caused /accelerated the problem.However, the customer is not attributing the patient's death or serious injury to the iabp.
|
|
Manufacturer Narrative
|
The production device history record (dhr) for this intra-aortic balloon pump (iabp) was not reviewed per company standard operating procedure since the device serial number was not provided.However, the customer did confirm that it was a maquet/ getinge iabp.No additional information has been received from the customer after various attempts were made requesting relevant data.If any pertinent information is received in the future, a supplemental report will be provided appropriately.
|
|
Event Description
|
The customer reported that the patient had a myocardial infarction (mi) and required intra-aortic balloon pump (iabp) therapy, which was inserted under fluoroscopy.This was reported to have been uneventful, and the patient was scheduled to be operated on when the patient's troponin levels dropped.As per hospital's ward protocol, the patient was put on a heparin infusion, and on the sixth (6th) postoperative day, it was reported that the patient had a retro-peritoneal bleed from the opposite groin to the iabp and was bleeding out.The heparin was stopped.The peritoneal bleed could have been evacuated, but was judged to be limited, and monitored instead.The patient subsequently went into renal failure, and died.The customer is questioning the use of heparin for the iabp patients and is specifically interested in the protocol for its use in iabp therapy, and is speculating if the use of heparin with the iabp may have caused /accelerated the problem.However, the customer is not attributing the patient's death or serious injury to the iabp.
|
|
Search Alerts/Recalls
|
|
|